This brand name is authorized in Austria, Spain, Hong Kong, Japan, Singapore
The drug NEUROLITE contains one active pharmaceutical ingredient (API):
|
1
Technetium ⁹⁹ᵐTc bicisate
UNII B005P07V07 - BICISATE DIHYDROCHLORIDE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09AA02 | Technetium (99mTc) bicisate | V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AA Technetium (99mTc) compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 60882 |
| Country: HK | Department of Health Drug Office | Identifier(s): 43086 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4300443A1024, 4300443A2020 |
| Country: SG | Health Sciences Authority | Identifier(s): 12644P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
